Year |
Citation |
Score |
2023 |
Taura J, López-Cano M, Fernández-Dueñas V, Ciruela F. Visualizing G Protein-Coupled Receptor-Receptor Interactions in Brain Using Proximity Ligation In Situ Assay. Current Protocols. 3: e794. PMID 37289022 DOI: 10.1002/cpz1.794 |
0.815 |
|
2023 |
Morató X, Fernández-Dueñas V, Pérez-Villamor P, Valle-León M, Vela JM, Merlos M, Burgueño J, Ciruela F. Development of a Novel σ Receptor Biosensor Based on Its Heterodimerization with Binding Immunoglobulin Protein in Living Cells. Acs Chemical Neuroscience. PMID 37191585 DOI: 10.1021/acschemneuro.3c00206 |
0.81 |
|
2022 |
Prieto-Díaz R, González-Gómez M, Fojo-Carballo H, Azuaje J, El Maatougui A, Majellaro M, Loza MI, Brea J, Fernández-Dueñas V, Paleo MR, Díaz-Holguín A, Garcia-Pinel B, Mallo-Abreu A, Estévez JC, Andújar-Arias A, et al. Exploring the Effect of Halogenation in a Series of Potent and Selective A Adenosine Receptor Antagonists. Journal of Medicinal Chemistry. PMID 36517209 DOI: 10.1021/acs.jmedchem.2c01768 |
0.574 |
|
2022 |
Crans RAJ, Wouters E, Valle-León M, Taura J, Massari CM, Fernández-Dueñas V, Stove CP, Ciruela F. Corrigendum: Striatal dopamine D2-muscarinic acetylcholine M1 receptor-receptor interaction in a model of movement disorders. Frontiers in Pharmacology. 13: 1075433. PMID 36467044 DOI: 10.3389/fphar.2022.1075433 |
0.807 |
|
2022 |
Sarasola LI, Del Torrent CL, Pérez-Arévalo A, Argerich J, Casajuana-Martín N, Chevigné A, Fernández-Dueñas V, Ferré S, Pardo L, Ciruela F. The ADORA1 mutation linked to early-onset Parkinson's disease alters adenosine A-A receptor heteromer formation and function. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 156: 113896. PMID 36279718 DOI: 10.1016/j.biopha.2022.113896 |
0.578 |
|
2021 |
Fernández-Dueñas V, Bonaventura J, Aso E, Luján R, Ferré S, Ciruela F. Overcoming the challenges of detecting gpcr oligomerization in the brain. Current Neuropharmacology. PMID 34736381 DOI: 10.2174/1570159X19666211104145727 |
0.618 |
|
2021 |
Hüll K, Fernández-Dueñas V, Schönberger M, López-Cano M, Trauner D, Ciruela F. Optical Control of Adenosine-Mediated Pain Modulation. Bioconjugate Chemistry. PMID 34448572 DOI: 10.1021/acs.bioconjchem.1c00387 |
0.79 |
|
2021 |
López-Cano M, Font J, Aso E, Sahlholm K, Cabré G, Giraldo J, De Koninck Y, Hernando J, Llebaria A, Fernández-Dueñas V, Ciruela F. Remote local photoactivation of morphine produces analgesia without opioid-related adverse effects. British Journal of Pharmacology. PMID 34363210 DOI: 10.1111/bph.15645 |
0.765 |
|
2021 |
Morató X, Garcia-Esparcia P, Argerich J, Llorens F, Zerr I, Paslawski W, Borràs E, Sabidó E, Petäjä-Repo UE, Fernández-Dueñas V, Ferrer I, Svenningsson P, Ciruela F. Ecto-GPR37: a potential biomarker for Parkinson's disease. Translational Neurodegeneration. 10: 8. PMID 33637132 DOI: 10.1186/s40035-021-00232-7 |
0.788 |
|
2020 |
Valle-León M, Callado LF, Aso E, Cajiao-Manrique MM, Sahlholm K, López-Cano M, Soler C, Altafaj X, Watanabe M, Ferré S, Fernández-Dueñas V, Menchón JM, Ciruela F. Decreased striatal adenosine A-dopamine D receptor heteromerization in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 33010795 DOI: 10.1038/s41386-020-00872-9 |
0.796 |
|
2020 |
Crans RAJ, Wouters E, Valle-León M, Taura J, Massari CM, Fernández-Dueñas V, Stove CP, Ciruela F. Striatal Dopamine D-Muscarinic Acetylcholine M Receptor-Receptor Interaction in a Model of Movement Disorders. Frontiers in Pharmacology. 11: 194. PMID 32231561 DOI: 10.3389/Fphar.2020.00194 |
0.814 |
|
2020 |
Fernández-Dueñas V, Qian M, Argerich J, Amaral C, Risseeuw MDP, Van Calenbergh S, Ciruela F. Design, Synthesis and Characterization of a New Series of Fluorescent Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulators. Molecules (Basel, Switzerland). 25. PMID 32230915 DOI: 10.3390/Molecules25071532 |
0.566 |
|
2020 |
Köfalvi A, Moreno E, Cordomí A, Cai NS, Fernández-Dueñas V, Ferreira SG, Guixà-González R, Sánchez-Soto M, Yano H, Casadó-Anguera V, Cunha RA, Sebastião AM, Ciruela F, Pardo L, Casadó V, et al. Control of glutamate release by complexes of adenosine and cannabinoid receptors. Bmc Biology. 18: 9. PMID 31973708 DOI: 10.1186/S12915-020-0739-0 |
0.6 |
|
2019 |
Lanznaster D, Massari CM, Marková V, Šimková T, Duroux R, Jacobson KA, Fernández-Dueñas V, Tasca CI, Ciruela F. Adenosine A-A Receptor-Receptor Interaction: Contribution to Guanosine-Mediated Effects. Cells. 8. PMID 31847113 DOI: 10.3390/Cells8121630 |
0.556 |
|
2019 |
López-Cano M, Fernández-Dueñas V, Ciruela F. Proximity Ligation Assay Image Analysis Protocol: Addressing Receptor-Receptor Interactions. Methods in Molecular Biology (Clifton, N.J.). 2040: 41-50. PMID 31432474 DOI: 10.1007/978-1-4939-9686-5_3 |
0.766 |
|
2019 |
Fernández-Dueñas V, Gómez-Soler M, Valle-León M, Watanabe M, Ferrer I, Ciruela F. Revealing Adenosine A-Dopamine D Receptor Heteromers in Parkinson's Disease Post-Mortem Brain through a New AlphaScreen-Based Assay. International Journal of Molecular Sciences. 20. PMID 31340557 DOI: 10.3390/Ijms20143600 |
0.816 |
|
2019 |
Soto D, Olivella M, Grau C, Armstrong J, Alcon C, Gasull X, Santos-Gómez A, Locubiche S, de Salazar MG, García-Díaz R, Gratacòs-Batlle E, Ramos-Vicente D, Chu-Van E, Colsch B, Fernández-Dueñas V, et al. l-Serine dietary supplementation is associated with clinical improvement of loss-of-function -related pediatric encephalopathy. Science Signaling. 12. PMID 31213567 DOI: 10.1126/Scisignal.Aaw0936 |
0.493 |
|
2019 |
López-Cano M, Font J, Llebaria A, Fernández-Dueñas V, Ciruela F. Optical Modulation of Metabotropic Glutamate Receptor Type 5 In Vivo Using a Photoactive Drug. Methods in Molecular Biology (Clifton, N.J.). 1947: 351-359. PMID 30969427 DOI: 10.1007/978-1-4939-9121-1_20 |
0.794 |
|
2019 |
Zanatta AP, Gonçalves R, Zanatta L, de Oliveria GT, Moraes ALL, Zamoner A, Fernández-Dueñas V, Lanznaster D, Ciruela F, Tasca CI, Delalande C, Menegaz D, Silva FRMB. New ionic targets of 3,3',5'-triiodothyronine at the plasma membrane of rat Sertoli cells. Biochimica Et Biophysica Acta. Biomembranes. PMID 30639285 DOI: 10.1016/J.Bbamem.2019.01.002 |
0.423 |
|
2019 |
Aso E, Fernández-Dueñas V, López-Cano M, Taura J, Watanabe M, Ferrer I, Luján R, Ciruela F. Adenosine A-Cannabinoid CB Receptor Heteromers in the Hippocampus: Cannabidiol Blunts Δ-Tetrahydrocannabinol-Induced Cognitive Impairment. Molecular Neurobiology. PMID 30610611 DOI: 10.1007/S12035-018-1456-3 |
0.816 |
|
2018 |
Morató X, Gonçalves FQ, Lopes JP, Jauregui O, Soler C, Fernández-Dueñas V, Cunha RA, Ciruela F. Chronic adenosine A receptor blockade induces locomotor sensitization and potentiates striatal LTD in GPR37 deficient mice. Journal of Neurochemistry. PMID 30578680 DOI: 10.1111/Jnc.14653 |
0.795 |
|
2018 |
Sahlholm K, Valle-León M, Fernández-Dueñas V, Ciruela F. Dopamine receptor heteromers: biasing antipsychotics. Future Medicinal Chemistry. PMID 30518245 DOI: 10.4155/Fmc-2018-0335 |
0.826 |
|
2018 |
Tasca CI, Lanznaster D, Oliveira KA, Fernández-Dueñas V, Ciruela F. Neuromodulatory Effects of Guanine-Based Purines in Health and Disease. Frontiers in Cellular Neuroscience. 12: 376. PMID 30459558 DOI: 10.3389/Fncel.2018.00376 |
0.546 |
|
2018 |
Núñez F, Taura J, Camacho J, López-Cano M, Fernández-Dueñas V, Castro N, Castro J, Ciruela F. PBF509, an Adenosine A Receptor Antagonist With Efficacy in Rodent Models of Movement Disorders. Frontiers in Pharmacology. 9: 1200. PMID 30405415 DOI: 10.3389/Fphar.2018.01200 |
0.823 |
|
2018 |
Gómez-Soler M, Cordobilla B, Morató X, Fernández-Dueñas V, Domingo JC, Ciruela F. Triglyceride Form of Docosahexaenoic Acid Mediates Neuroprotection in Experimental Parkinsonism. Frontiers in Neuroscience. 12: 604. PMID 30233293 DOI: 10.3389/Fnins.2018.00604 |
0.792 |
|
2018 |
Jung C, Fernández-Dueñas V, Plata C, Garcia-Elias A, Ciruela F, Fernández-Fernández JM, Valverde MA. Functional coupling of GABA receptors and the channel TRPV4 mediates rapid progesterone signaling in the oviduct. Science Signaling. 11. PMID 30108184 DOI: 10.1126/Scisignal.Aam6558 |
0.514 |
|
2018 |
Morató X, Luján R, Gonçalves N, Watanabe M, Altafaj X, Carvalho AL, Fernández-Dueñas V, Cunha RA, Ciruela F. Metabotropic glutamate type 5 receptor requires contactin-associated protein 1 to control memory formation. Human Molecular Genetics. PMID 30010864 DOI: 10.1093/Hmg/Ddy264 |
0.784 |
|
2018 |
Sahlholm K, Valle-Leon M, Taura J, Fernandez-Duenas V, Ciruela F. Effects of the Dopamine Stabilizer, Pridopidine, on Basal and Phencyclidine-Induced Locomotion: Role of Dopamine D2 and Sigma-1 Receptors. Cns & Neurological Disorders Drug Targets. PMID 29952269 DOI: 10.2174/1871527317666180627103337 |
0.82 |
|
2018 |
Taura J, Nolen EG, Cabré G, Hernando J, Squarcialupi L, López-Cano M, Jacobson KA, Fernández-Dueñas V, Ciruela F. Remote control of movement disorders using a photoactive adenosine A receptor antagonist. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 29859955 DOI: 10.1016/J.Jconrel.2018.05.033 |
0.843 |
|
2018 |
Sahlholm K, Valle-León M, Fernández-Dueñas V, Ciruela F. Pridopidine Reverses Phencyclidine-Induced Memory Impairment. Frontiers in Pharmacology. 9: 338. PMID 29692729 DOI: 10.3389/Fphar.2018.00338 |
0.81 |
|
2018 |
Fernandez-Duenas V, Ferré S, Ciruela F. Adenosine A-dopamine Dreceptor heteromers operate striatal function: impact on Parkinson's disease pharmacotherapeutics. Neural Regeneration Research. 13: 241-243. PMID 29557372 DOI: 10.4103/1673-5374.226388 |
0.519 |
|
2018 |
Font J, López-Cano M, Notartomaso S, Scarselli P, Di Prieto P, Bresolí-Obach R, Battaglia G, Malhaire F, Rovira X, Catena J, Giraldo J, Pin JP, Fernández-Dueñas V, Goudet C, Nonell S, et al. Correction: Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator. Elife. 7. PMID 29313801 DOI: 10.7554/Elife.34752 |
0.784 |
|
2017 |
López-Cano M, Fernández-Dueñas V, Llebaria A, Ciruela F. Formalin Murine Model of Pain. Bio-Protocol. 7: e2628. PMID 34595296 DOI: 10.21769/BioProtoc.2628 |
0.743 |
|
2017 |
Fernández-Dueñas V, Pérez-Arévalo A, Altafaj X, Ferré S, Ciruela F. Adenosine A1-A2A Receptor Heteromer as a Possible Target for Early-Onset Parkinson's Disease. Frontiers in Neuroscience. 11: 652. PMID 29213228 DOI: 10.3389/Fnins.2017.00652 |
0.571 |
|
2017 |
Massari CM, López-Cano M, Núñez F, Fernández-Dueñas V, Tasca CI, Ciruela F. Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder. Frontiers in Pharmacology. 8: 700. PMID 29046640 DOI: 10.3389/Fphar.2017.00700 |
0.784 |
|
2017 |
Morató X, Luján R, López-Cano M, Gandía J, Stagljar I, Watanabe M, Cunha RA, Fernández-Dueñas V, Ciruela F. The Parkinson's disease-associated GPR37 receptor interacts with striatal adenosine A2A receptor controlling its cell surface expression and function in vivo. Scientific Reports. 7: 9452. PMID 28842709 DOI: 10.1038/S41598-017-10147-X |
0.844 |
|
2017 |
Sahlholm K, Gómez-Soler M, Valle-León M, López-Cano M, Taura JJ, Ciruela F, Fernández-Dueñas V. Antipsychotic-Like Efficacy of Dopamine D2 Receptor-Biased Ligands is Dependent on Adenosine A2A Receptor Expression. Molecular Neurobiology. PMID 28779351 DOI: 10.1007/S12035-017-0696-Y |
0.782 |
|
2017 |
Soto D, Olivella M, Grau C, Armstrong J, Alcon C, Gasull X, Gómez de Salazar M, Gratacòs-Batlle E, Ramos-Vicente D, Fernández-Dueñas V, Ciruela F, Bayés À, Sindreu C, López-Sala A, García-Cazorla À, et al. Rett-like Severe Encephalopathy Caused by a De Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement. Biological Psychiatry. PMID 28734458 DOI: 10.1016/J.Biopsych.2017.05.028 |
0.468 |
|
2017 |
Oliveira PA, Dalton JAR, López-Cano M, Ricarte A, Morató X, Matheus FC, Cunha AS, Müller CE, Takahashi RN, Fernández-Dueñas V, Giraldo J, Prediger RD, Ciruela F. Angiotensin II type 1/adenosine A 2A receptor oligomers: a novel target for tardive dyskinesia. Scientific Reports. 7: 1857. PMID 28500295 DOI: 10.1038/S41598-017-02037-Z |
0.847 |
|
2017 |
Font J, López-Cano M, Notartomaso S, Scarselli P, Di Pietro P, Bresolí-Obach R, Battaglia G, Malhaire F, Rovira X, Catena J, Giraldo J, Pin JP, Fernández-Dueñas V, Goudet C, Nonell S, et al. Optical control of pain in vivo with a photoactive mGlu5 receptor negative allosteric modulator. Elife. 6. PMID 28395733 DOI: 10.7554/Elife.23545 |
0.807 |
|
2017 |
Fernández-Dueñas V, Azuaje J, Morató X, Cordobilla B, Domingo JC, Sotelo E, Ciruela F. Synthesis and Characterization of a New Bivalent Ligand Combining Caffeine and Docosahexaenoic Acid. Molecules (Basel, Switzerland). 22. PMID 28264466 DOI: 10.3390/Molecules22030366 |
0.807 |
|
2017 |
Fernández-Dueñas V, Burgueño J, Ciruela F. Exploring Drug-Receptor Interaction Kinetics: Lessons from a Sigma-1 Receptor Transmembrane Biosensor. Frontiers in Pharmacology. 8: 4. PMID 28144220 DOI: 10.3389/Fphar.2017.00004 |
0.824 |
|
2016 |
Rial D, Morató X, Real JI, Gonçalves FQ, Stagljar I, Pereira FC, Fernández-Dueñas V, Cunha RA, Ciruela F. Parkinson's disease-associated GPR37 receptor regulates cocaine-mediated synaptic depression in corticostriatal synapses. Neuroscience Letters. PMID 28007645 DOI: 10.1016/J.Neulet.2016.12.040 |
0.766 |
|
2016 |
Gaitán-Peñas H, Gradogna A, Laparra-Cuervo L, Solsona C, Fernández-Dueñas V, Barrallo-Gimeno A, Ciruela F, Lakadamyali M, Pusch M, Estévez R. Investigation of LRRC8-Mediated Volume-Regulated Anion Currents in Xenopus Oocytes. Biophysical Journal. 111: 1429-1443. PMID 27705766 DOI: 10.1016/J.Bpj.2016.08.030 |
0.458 |
|
2016 |
Di Liberto V, Mudò G, Garozzo R, Frinchi M, Fernandez-Dueñas V, Di Iorio P, Ciccarelli R, Caciagli F, Condorelli DF, Ciruela F, Belluardo N. The Guanine-Based Purinergic System: The Tale of An Orphan Neuromodulation. Frontiers in Pharmacology. 7: 158. PMID 27378923 DOI: 10.3389/Fphar.2016.00158 |
0.609 |
|
2015 |
Taura J, Fernández-Dueñas V, Ciruela F. Visualizing G Protein-Coupled Receptor-Receptor Interactions in Brain Using Proximity Ligation In Situ Assay. Current Protocols in Cell Biology / Editorial Board, Juan S. Bonifacino ... [Et Al.]. 67: 17.17.1-17.17.16. PMID 26061241 DOI: 10.1002/0471143030.Cb1717S67 |
0.836 |
|
2015 |
Ciruela F, Fernández-Dueñas V, Jacobson KA. Lighting up G protein-coupled purinergic receptors with engineered fluorescent ligands. Neuropharmacology. PMID 25890205 DOI: 10.1016/J.Neuropharm.2015.04.001 |
0.57 |
|
2015 |
Gandía J, Morató X, Stagljar I, Fernández-Dueñas V, Ciruela F. Adenosine A2A receptor-mediated control of pilocarpine-induced tremulous jaw movements is Parkinson's disease-associated GPR37 receptor-dependent. Behavioural Brain Research. 288: 103-6. PMID 25862943 DOI: 10.1016/J.Bbr.2015.04.001 |
0.843 |
|
2015 |
Lopes JP, Morató X, Souza C, Pinhal C, Machado NJ, Canas PM, Silva HB, Stagljar I, Gandía J, Fernández-Dueñas V, Luján R, Cunha RA, Ciruela F. The role of parkinson's disease-associated receptor GPR37 in the hippocampus: functional interplay with the adenosinergic system. Journal of Neurochemistry. 134: 135-46. PMID 25824528 DOI: 10.1111/Jnc.13109 |
0.809 |
|
2015 |
Ciruela F, Fernández-Dueñas V. GPCR oligomerization analysis by means of BRET and dFRAP. Methods in Molecular Biology (Clifton, N.J.). 1272: 133-41. PMID 25563182 DOI: 10.1007/978-1-4939-2336-6_10 |
0.494 |
|
2015 |
Fernández-Dueñas V, Taura JJ, Cottet M, Gómez-Soler M, López-Cano M, Ledent C, Watanabe M, Trinquet E, Pin JP, Luján R, Durroux T, Ciruela F. Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats. Disease Models & Mechanisms. 8: 57-63. PMID 25398851 DOI: 10.1242/Dmm.018143 |
0.795 |
|
2014 |
Fernández-Dueñas V, Gómez-Soler M, López-Cano M, Taura JJ, Ledent C, Watanabe M, Jacobson KA, Vilardaga JP, Ciruela F. Uncovering caffeine's adenosine A2A receptor inverse agonism in experimental parkinsonism. Acs Chemical Biology. 9: 2496-501. PMID 25268872 DOI: 10.1021/Cb5005383 |
0.82 |
|
2014 |
Bahamonde MI, Taura J, Paoletta S, Gakh AA, Chakraborty S, Hernando J, Fernández-Dueñas V, Jacobson KA, Gorostiza P, Ciruela F. Photomodulation of G protein-coupled adenosine receptors by a novel light-switchable ligand. Bioconjugate Chemistry. 25: 1847-54. PMID 25248077 DOI: 10.1021/Bc5003373 |
0.845 |
|
2014 |
Ciruela F, Vallano A, Cuffí ML, Carbonell L, Sánchez S, Arnau JM, Tasca C, Fernández-Dueñas V, Gómez-Soler M. Deciphering G protein-coupled receptor biology with fluorescence-based methods. Current Pharmaceutical Biotechnology. 15: 962-70. PMID 25213309 DOI: 10.2174/1389201015666140909125119 |
0.823 |
|
2014 |
Ciruela F, Jacobson KA, Fernández-Dueñas V. Portraying G protein-coupled receptors with fluorescent ligands. Acs Chemical Biology. 9: 1918-28. PMID 25010291 DOI: 10.1021/Cb5004042 |
0.55 |
|
2014 |
Villar-Menéndez I, Nuñez F, Díaz-Sánchez S, Albasanz JL, Taura J, Fernández-Dueñas V, Ferrer I, Martín M, Ciruela F, Barrachina M. Striatal adenosine A2A receptor expression is controlled by S-adenosyl-L-methionine-mediated methylation. Purinergic Signalling. 10: 523-8. PMID 24943396 DOI: 10.1007/S11302-014-9417-4 |
0.807 |
|
2013 |
Gandía J, Fernández-Dueñas V, Morató X, Caltabiano G, González-Muñiz R, Pardo L, Stagljar I, Ciruela F. The Parkinson's disease-associated GPR37 receptor-mediated cytotoxicity is controlled by its intracellular cysteine-rich domain. Journal of Neurochemistry. 125: 362-72. PMID 23398388 DOI: 10.1111/Jnc.12196 |
0.826 |
|
2012 |
Fernández-Dueñas V, Poveda R, Sánchez S, Ciruela F. Synergistic interaction between fentanyl and a tramadol: paracetamol combination on the inhibition of nociception in mice. Journal of Pharmacological Sciences. 118: 299-302. PMID 22302020 DOI: 10.1254/Jphs.11161Sc |
0.505 |
|
2011 |
Vallano A, Fernandez-Duenas V, Pedros C, Arnau JM, Ciruela F. An update on adenosine A2A receptors as drug target in Parkinson's disease. Cns & Neurological Disorders Drug Targets. 10: 659-69. PMID 21838670 DOI: 10.2174/187152711797247803 |
0.687 |
|
2011 |
López-Hernández T, Sirisi S, Capdevila-Nortes X, Montolio M, Fernández-Dueñas V, Scheper GC, van der Knaap MS, Casquero P, Ciruela F, Ferrer I, Nunes V, Estévez R. Molecular mechanisms of MLC1 and GLIALCAM mutations in megalencephalic leukoencephalopathy with subcortical cysts. Human Molecular Genetics. 20: 3266-77. PMID 21624973 DOI: 10.1093/Hmg/Ddr238 |
0.409 |
|
2011 |
Caballero M, Núñez F, Ahern S, Cuffí ML, Carbonell L, Sánchez S, Fernández-Dueñas V, Ciruela F. Caffeine improves attention deficit in neonatal 6-OHDA lesioned rats, an animal model of attention deficit hyperactivity disorder (ADHD). Neuroscience Letters. 494: 44-8. PMID 21362462 DOI: 10.1016/J.Neulet.2011.02.050 |
0.443 |
|
2011 |
Fernández-Dueñas V, Poveda R, Fernández A, Sánchez S, Planas E, Ciruela F. Fentanyl-trazodone-paracetamol triple drug combination: multimodal analgesia in a mouse model of visceral pain. Pharmacology, Biochemistry, and Behavior. 98: 331-6. PMID 21296105 DOI: 10.1016/J.Pbb.2011.01.023 |
0.512 |
|
2010 |
Ciruela F, Vilardaga JP, Fernández-Dueñas V. Lighting up multiprotein complexes: lessons from GPCR oligomerization. Trends in Biotechnology. 28: 407-15. PMID 20542584 DOI: 10.1016/J.Tibtech.2010.05.002 |
0.508 |
|
2010 |
Fernández-Dueñas V, Ciruela F, Gandía J, Sánchez S, Planas E, Poveda R. Histamine H3 receptor activation potentiates peripheral opioid-mediated antinociception: substance P role in peripheral inflammation in mice. European Journal of Pharmacology. 638: 72-7. PMID 20435034 DOI: 10.1016/J.Ejphar.2010.04.022 |
0.795 |
|
2010 |
Ciruela F, Albergaria C, Soriano A, Cuffí L, Carbonell L, Sánchez S, Gandía J, Fernández-Dueñas V. Adenosine receptors interacting proteins (ARIPs): Behind the biology of adenosine signaling. Biochimica Et Biophysica Acta. 1798: 9-20. PMID 19883624 DOI: 10.1016/J.Bbamem.2009.10.016 |
0.838 |
|
2009 |
Canela L, Fernández-Dueñas V, Albergaria C, Watanabe M, Lluís C, Mallol J, Canela EI, Franco R, Luján R, Ciruela F. The association of metabotropic glutamate receptor type 5 with the neuronal Ca2+-binding protein 2 modulates receptor function. Journal of Neurochemistry. 111: 555-67. PMID 19694902 DOI: 10.1111/J.1471-4159.2009.06348.X |
0.828 |
|
Show low-probability matches. |